1137 / 1161
Normal tissue sparing
•
The dosimetry benefit is obvious
•
What
clinical benefit
does this confer?
➢
Largely unknown
➢
Needs investigation
➢
Requires long follow up
•
Connecting dose (dose difference) to clinical outcome (differences)
is crucial